Evaluation of the Combined Effects of Flaxseed Consumption and Fasting Mimicking Diet (FMD) on Patients with Non-Alcoholic Fatty Liver Diseases (NAFLD): a Randomized Control Trial

Phase 2

Recruiting

• Conditions: on-alcoholic fatty liver.; Fatty (change of) liver, not elsewhere classified; K76.0

• Registration Number: IRCT20100524004010N36
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-04-03

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Age over 18 years
Having evidence of non-alcoholic steatohepatitis and CAP score over 263
Not having a history of alcohol and drug abuse
Absence of other chronic and acute liver disorders
No use of chemical and herbal medicines that affect the liver and weight
Not having a chronic inflammatory disease and no history of cancer
No treatment with anti-inflammatory drugs, corticosteroids and hormones
Not having lost more than 8 percent of the weight in the last 6 months
Blood pressure less than 140/90 mmHg
Not having uncontrolled kidney disease, pituitary disorders, thyroid, cardiovascular diseases, diabetes and digestive system disorders that affect absorption
No history of excessive consumption of flaxseed
Not having clinically diagnosed psychiatric disorders that impair the patient's ability to provide written informed consent
Willingness to participate in the study

Exclusion Criteria

Having clinically diagnosed psychiatric disorders that impair the patient's ability to provide written informed consent
Use of other supplements
Unwillingness to participate in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified